Kuros Biosciences AG (LON:0RHR)
25.89
+1.07 (4.31%)
At close: Apr 29, 2025
Kuros Biosciences AG Revenue
In the year 2024, Kuros Biosciences AG had annual revenue of 75.56M CHF with 125.11% growth.
Revenue
75.56M CHF
Revenue Growth
+179.89%
P/S Ratio
13.92
Revenue / Employee
619.30K CHF
Employees
122
Market Cap
927.05M GBP
Revenue Chart
* This company reports financials in CHF.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 75.56M | 41.99M | 125.11% |
Dec 31, 2023 | 33.56M | 15.58M | 86.61% |
Dec 31, 2022 | 17.99M | 4.17M | 30.19% |
Dec 31, 2021 | 13.82M | 9.78M | 242.04% |
Dec 31, 2020 | 4.04M | 1.48M | 57.71% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.38B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Oxford Nanopore Technologies | 183.19M |